These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33229545)

  • 1. Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Abrams RPM; Yasgar A; Teramoto T; Lee MH; Dorjsuren D; Eastman RT; Malik N; Zakharov AV; Li W; Bachani M; Brimacombe K; Steiner JP; Hall MD; Balasubramanian A; Jadhav A; Padmanabhan R; Simeonov A; Nath A
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31365-31375. PubMed ID: 33229545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
    Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
    J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
    Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Ascomycin against Zika virus infection through screening of natural product library.
    Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
    Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
    Loe MWC; Lee RCH; Chu JJH
    Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus
    Li Z; Lang Y; Sakamuru S; Samrat S; Trudeau N; Kuo L; Rugenstein N; Tharappel A; D'Brant L; Koetzner CA; Hu S; Zhang J; Huang R; Kramer LD; Butler D; Xia M; Li H
    Emerg Microbes Infect; 2020 Dec; 9(1):2404-2416. PubMed ID: 33078696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Antiviral Peptide from
    Ji M; Zhu T; Xing M; Luan N; Mwangi J; Yan X; Mo G; Rong M; Li B; Lai R; Jin L
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31658707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.
    Zhang JW; Wang H; Liu J; Ma L; Hua RH; Bu ZG
    Virol Sin; 2021 Jun; 36(3):476-489. PubMed ID: 33231855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.
    Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S
    J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a small compound that specifically inhibits Zika virus in vitro and in vivo by targeting the NS2B-NS3 protease.
    Miao J; Yuan H; Rao J; Zou J; Yang K; Peng G; Cao S; Chen H; Song Y
    Antiviral Res; 2022 Mar; 199():105255. PubMed ID: 35143853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors.
    Lima CS; Mottin M; de Assis LR; Mesquita NCMR; Sousa BKP; Coimbra LD; Santos KB; Zorn KM; Guido RVC; Ekins S; Marques RE; Proença-Modena JL; Oliva G; Andrade CH; Regasini LO
    Bioorg Chem; 2021 Apr; 109():104719. PubMed ID: 33636437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
    Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
    Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.